Clinical Trial Update: Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

View source ↗

Summary

Observational study to evaluate the safety of DILATREND SR Capsule in Korean patients with essential hypertension, chronic stable angina, and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Heart Failure
• Stable Angina

Drugs mentioned

• DILATREND SR Capsule (diltiazem extended-release)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Essential Hypertension, Chronic Stable Angina | Status: UNKNOWN